AU7420591A - Carbapenem compounds - Google Patents

Carbapenem compounds

Info

Publication number
AU7420591A
AU7420591A AU74205/91A AU7420591A AU7420591A AU 7420591 A AU7420591 A AU 7420591A AU 74205/91 A AU74205/91 A AU 74205/91A AU 7420591 A AU7420591 A AU 7420591A AU 7420591 A AU7420591 A AU 7420591A
Authority
AU
Australia
Prior art keywords
carbapenem compounds
carbapenem
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU74205/91A
Other languages
English (en)
Inventor
Scott Louis Dax
Dennis Dalton Keith
Pamela Loreen Rossman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU7420591A publication Critical patent/AU7420591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU74205/91A 1990-04-09 1991-04-08 Carbapenem compounds Abandoned AU7420591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09
US506135 1990-04-09

Publications (1)

Publication Number Publication Date
AU7420591A true AU7420591A (en) 1991-10-10

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU74205/91A Abandoned AU7420591A (en) 1990-04-09 1991-04-08 Carbapenem compounds

Country Status (17)

Country Link
EP (1) EP0451764A1 (show.php)
JP (1) JPH04234884A (show.php)
AU (1) AU7420591A (show.php)
BR (1) BR9101418A (show.php)
CA (1) CA2039987A1 (show.php)
CS (1) CS94391A2 (show.php)
FI (1) FI911666A7 (show.php)
HU (1) HUT57769A (show.php)
IE (1) IE911161A1 (show.php)
IL (1) IL97797A0 (show.php)
MC (1) MC2262A1 (show.php)
MX (1) MX25231A (show.php)
NO (1) NO911357L (show.php)
PT (1) PT97287A (show.php)
TW (1) TW216420B (show.php)
YU (1) YU62991A (show.php)
ZA (1) ZA912279B (show.php)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
SG47533A1 (en) * 1990-04-18 1998-04-17 Procter & Gamble Pharma Antimicrobial quinolonyl lactams
EP0606336B1 (en) * 1991-10-01 1997-03-19 PROCTER & GAMBLE PHARMACEUTICALS, INC. Process for making antimicrobial quinolonyl lactams
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
ATE190972T1 (de) * 1994-08-02 2000-04-15 Procter & Gamble Verfahren zur herstellung von antimikrobiellen verbindungen
MX9700872A (es) * 1994-08-02 1997-05-31 Procter & Gamble Procedimiento para producir antimicrobianos de quinolonil-lactama y compuestos intermediarios novedosos.
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
ATE247086T1 (de) * 1997-01-21 2003-08-15 Merck & Co Inc Verfahren zur herstellung von zwischenprodukten des carbapenems
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams
EP0997466A1 (en) * 1988-10-24 2000-05-03 PROCTER & GAMBLE PHARMACEUTICALS, INC. Novel antimicrobial lactam-quinolones
ES2148135T3 (es) * 1988-10-24 2000-10-16 Norwich Eaton Pharma Nuevos esteres antimicrobianos de quinolonil lactamas.

Also Published As

Publication number Publication date
MX25231A (es) 1993-10-01
CA2039987A1 (en) 1991-10-10
TW216420B (show.php) 1993-11-21
YU62991A (sh) 1994-04-05
HU911132D0 (en) 1991-10-28
PT97287A (pt) 1992-01-31
BR9101418A (pt) 1991-11-26
FI911666A7 (fi) 1991-10-10
ZA912279B (en) 1992-02-26
HUT57769A (en) 1991-12-30
JPH04234884A (ja) 1992-08-24
IE911161A1 (en) 1991-10-09
IL97797A0 (en) 1992-06-21
NO911357D0 (no) 1991-04-08
NO911357L (no) 1991-10-10
EP0451764A1 (en) 1991-10-16
MC2262A1 (fr) 1993-04-26
FI911666A0 (fi) 1991-04-08
CS94391A2 (en) 1991-11-12

Similar Documents

Publication Publication Date Title
AU657350B2 (en) Heterocyclic compounds
AU639126B2 (en) Oxorapamycin
AU2056992A (en) Heterocyclic compounds
AU8375591A (en) Azacyclic compounds
AU1272295A (en) Proinsulin-like compounds
AU6971794A (en) Novel compounds
AU8351791A (en) Heterocyclic compounds
AU3803593A (en) Compounds
AU7420591A (en) Carbapenem compounds
AU7867491A (en) Compounds
AU5261093A (en) Aminoalkylphenyl compounds
AU685767B2 (en) Substituted benzazepinones
AU7628591A (en) Heterocyclic compounds
AU1975092A (en) Compounds
AU7726391A (en) Slitterscorer
AU8079591A (en) Bisheterocyclic compound
AU8542991A (en) Heterocyclic compounds
AU8624791A (en) Compounds
AU7891891A (en) Pyrrolopyridazine compounds
AU2894492A (en) Heterocyclic compounds
AU7566691A (en) Compostor
AU3048492A (en) New compounds
AU7587991A (en) Electrodermatome
AU7709991A (en) Phenoxyphenylsulphonyl compounds
AU5922994A (en) Oxazinobenzazole compounds